Healio - Serotonin Receptor Shows Promise in Hypoactive Sexual Desire Disorder

James Simon, M.D., clinical professor of obstetrics and gynecology, was mentioned in an article in Healio's Endocrine Today on his study finding Flibanserin, a serotonin receptor 1A agonist/serotonin receptor 2A antagonist, safely and effectively improved the sexual interactions of naturally postmenopausal women diagnosed with hypoactive sexual desire disorder.

Latest News

Anton N. Sidawy, MD, MPH ’99, FACS, DFSVS, MAMSE, Lewis B. Saltz Chair of the Department of Surgery and professor of surgery at the George Washington University School of Medicine and Health Sciences in Washington, D.C., was installed as the 106th President of the American College of Surgeons (ACS…
The George Washington University School of Medicine and Health Sciences recently welcomed the Fall 2025 cohort of the Integrated Biomedical Sciences (IBS) PhD Program, marking the program’s 30th class of doctoral students.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the appointment of Brandon Beattie, MMSc, PA-C, assistant professor of Physician Assistant (PA) studies, to serve as the director of the PA Program.